文献速递乳腺技术与安全US

超声造影与超声弹性成像对BI-RADS 4类不可触及乳腺肿块处理的预测价值

Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.
PubMed 文献 · Eur J Radiol · 2024-02-28

前瞻性纳入2018年1月起连续就诊的乳腺肿瘤患者,回顾性分析146例不可触及BI-RADS 4类肿块,以手术切除后病理为金标准。超声联合超声造影诊断BI-RADS 4类不可触及肿块的AUC为0.954,优于联合剪切波弹性成像的0.798和联合应变弹性成像的0.741(P<0.001);超声造影对BI-RADS 4a类肿块重分类改善更明显。

要点

  • 超声联合超声造影诊断BI-RADS 4类不可触及肿块的AUC为0.954,优于联合剪切波弹性成像的0.798和联合应变弹性成像的0.741。
  • 超声造影对BI-RADS 4a类肿块重分类的AUC为0.943,优于剪切波弹性成像的0.762和应变弹性成像的0.675(P<0.001)。
  • 采用超声造影降级策略对BI-RADS 4a和4b类肿块的阴性预测值为95.2%至100.0%。

核心结论

  • 超声造影在提升不可触及BI-RADS 4类乳腺肿块的风险评估和诊断准确性方面较弹性成像影响更显著,尤其对BI-RADS 4a类亚组肿块可能带来更大获益。

研究设计与样本

  • 前瞻性研究连续纳入2018年1月起就诊的乳腺肿瘤患者,回顾性分析其中以不可触及肿块为主诉者146例共146个肿块,以手术切除后病理为金标准,采用二元logistic回归多因素分析筛选独立危险因素,并用受试者工作特征曲线比较不同模态的预测效能。

关键影像表现/征象

  • 超声造影动脉期指标采用造影剂到达时间参数成像处理模式分析,弹性成像图像上评估定量和定性指标。
  • 超声造影升级列线图策略的独立预测危险因素包括不规则增强形态、增强边缘显示不清、增强时间较早、周围血管增多和造影剂滞留。

诊断标准与关键数值

  • 超声联合超声造影诊断BI-RADS 4类不可触及肿块的AUC为0.954,高于超声联合剪切波弹性成像的0.798和超声联合应变弹性成像的0.741(P<0.001)。
  • BI-RADS 4a类肿块重分类的AUC:超声联合超声造影0.943 vs 超声联合剪切波弹性成像0.762 vs 超声联合应变弹性成像0.675(P<0.001)。
  • BI-RADS 4b类肿块重分类的AUC:超声联合超声造影0.950 vs 超声联合剪切波弹性成像0.885 vs 超声联合应变弹性成像0.796(P>0.05)。
  • 超声造影降级策略对BI-RADS 4a和4b类肿块的阴性预测值范围为95.2%至100.0%。
  • 基于不规则增强形态、增强边缘显示不清、增强时间较早、周围血管增多和造影剂滞留建立的升级列线图策略AUC为0.947,校准良好。

临床应用与阅片要点

  • 对不可触及BI-RADS 4类乳腺肿块,超声联合超声造影的诊断效能优于联合剪切波弹性成像或应变弹性成像。
  • 超声造影对BI-RADS 4a类不可触及肿块的重分类改善较BI-RADS 4b类更明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The objective of this study was to investigate the independent risk factors and associated predictive values of contrast-enhanced ultrasound (CEUS), shear wave elastography (SWE), and strain elastography (SE) for high-risk lesions (HRL) and malignant tumors (MT) among nonpalpable breast masses classified as BI-RADS category 4 on conventional ultrasound.

METHODS: This prospective study involved consecutively admitted patients with breast tumors from January 2018, aiming to explore the management of BI-RADS category 4 breast tumors using CEUS and elastography. We conducted a retrospective review of patient data, focusing on those with a history of a nonpalpable mass as the primary complaint. Pathologic findings after surgical resection served as the gold standard. The CEUS arterial-phase indices were analyzed using contrast agent arrival-time parametric imaging processing mode, while quantitative and qualitative indices were examined on ES images. Independent risk factors were identified through binary logistic regression multifactorial analysis. The predictive efficacy of different modalities was compared using a receiver operating characteristics curve. Subsequently, a nomogram for predicting the risk of HRL/MT was established based on a multifactorial logistic regression model.

RESULTS: A total of 146 breast masses from 146 patients were included, comprising 80 benign tumors, 12 HRLs, and 54 MTs based on the final pathology. There was no significant difference in pathologic size between the benign and HRL/MT groups [8.00(6.25,10.00) vs. 9.00(6.00,10.00), P = 0.506]. The diagnostic efficacy of US plus CEUS exceeded that of US plus SWE/SE for BI-RADS 4 nonpalpable masses, with an AUC of 0.954 compared to 0.798/0.741 (P < 0.001). Further stratified analysis revealed a more pronounced improvement for reclassification of BI-RADS 4a masses (AUC: 0.943 vs. 0.762/0.675, P < 0.001) than BI-RADS 4b (AUC:0.950 vs. 0.885/0.796, P>0.05) with the assistance of CEUS than SWE/SE. Employing downgrade CEUS strategies resulted in negative predictive values ranging from 95.2 % to 100.0 % for BI-RADS 4a and 4b masses. Conversely, using upgrade nomogram strategies, which included the independent predictive risk factors of irregular enhanced shape, poor defined enhanced margin, earlier enhanced time, increased surrounding vessels, and presence of contrast agent retention, the diagnostic performance achieved an AUC of 0.947 with good calibration.

CONCLUSION: After investigating the potential of CEUS and ES in improving risk assessment and diagnostic accuracy for nonpalpable BI-RADS category 4 breast masses, it is evident that CEUS has a more significant impact on enhancing classification compared to ES, particularly for BI-RADS 4a subgroup masses. This finding suggests that CEUS may offer greater benefits in improving risk assessment and diagnostic accuracy for this specific subgroup of breast masses.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Niu Q, Zhao L, Wang R, et al. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses. Eur J Radiol. 2024. PMID: 38422608. doi:10.1016/j.ejrad.2024.111391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。